Latin America Hypodermic Syringes & Needles Market Analysis

Latin America Hypodermic Syringes & Needles Market Analysis

Needles segment accounted for around 53% revenue share of the Latin America hypodermic syringes & needles market in 2022 and is set to record substantial growth over 2023-2032. A hypodermic needle is essential in research that requires sterile conditions. Due to its sleek surface, airborne viruses do not get stuck on an uneven surface, which reduces contamination during sterile substrate injection, thereby contributing to its increasing adoption rate. Furthermore, the substantial rise in injection-based treatments and therapeutic systems is expected to positively influence segment expansion.
 

By application, Latin America hypodermic syringes & needles market from the drug delivery segment generated USD 183 million in 2022. The mounting product usage for delivery of pharmaceuticals during the treatments of a wide range of diseases along with the long-term strategies and investments by the state and federal public health partners to support the healthcare sector in overcoming the difficulties caused by the pandemic are likely to boost the segment share.
 

Based on usability, the Latin America hypodermic syringes & needles market from the disposable segment is projected to reach USD 506 million by 2032. In recent years, the increasing availability of ready-to-use sterilized disposable hypodermic syringes and needles has proven to be of significant convenience to medical professionals, hospitals, and nursing homes. Disposable syringes and needles are the most often used medical instruments for intravenous or intramuscular injections to avoid disease transmission since they are designed to be discarded after one use. Hence, these benefits of the product are set to promote their preference through 2032.
 

Latin America hypodermic syringes & needles market from the hospitals end-use segment is set to be worth more than USD 340 million by 2032 backed by the soaring number of diagnostic procedures and increasing patient admissions with chronic conditions, which is slated to propel product demand in hospitals. Thus, rising hospital visits and the upsurge in the incidences of chronic disorders, such as chronic respiratory conditions, diabetes, cancer, cardiovascular ailments, orthopedic disorders, and other conditions, are foreseen to positively influence the segment outlook.
 

Brazil hypodermic syringes & needles market is projected to amass more than USD 179 million in revenue by 2032. Brazil ranks third in the world in the prevalence of type 1 diabetes cases among children and adolescents aged between 0-14 years, which is expected to boost product usage. Additionally, industry participants are taking efforts to expand their services, which is likely to bolster market progression.